BBC

Virtus LifeSci Biotech Clinical Trials ETF

26.51 USD
-1.27 (-4.58%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Virtus LifeSci Biotech Clinical Trials ETF stock is up 3.92% since 30 days ago. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 July’s closed higher than June.